Clinical Trial Update: An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies [Phase 1]

View source ↗

Summary

Open-label Phase 1 safety and tolerability study of INCB062079 in patients with advanced hepatocellular carcinoma and other malignancies; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Esophageal Cancer
• Hepatocellular Carcinoma
• Nasopharyngeal Cancer
• Ovarian Cancer
• Solid Tumors

Drugs mentioned

• INCB062079

Snippet

Sponsor: Incyte Corporation | Conditions: Hepatocellular Carcinoma (HCC), Cholangiocarcinoma | Phase 1 | Status: TERMINATED